Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease.

Neuroscience2010Xu K, Xu YH, Chen JF, et al.

Study designOther primary literature

SubjectAnimal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsCaffeineCorpus StriatumDopamineMaleMiceMice, Inbred C57BLNeuroprotective AgentsParkinson Disease, SecondaryTheophyllineTime Factors

DOI 10.1016/j.neuroscience.2010.02.020

PMID 20167258

View source →